Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas

Brief description of study

Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas


Clinical Study Identifier: s20-01692
ClinicalTrials.gov Identifier: NCT04617002
Principal Investigator: Jessica Clymer.
Other Investigator: Devorah Segal.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.